A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities
1 other identifier
observational
5,000
1 country
1
Brief Summary
The primary objective of this study is to build a well characterized cohort of patients that will be used to determine the genetic variants associated with obstructive sleep apnea (OSA)and its co-morbidities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 10, 2013
CompletedFirst Posted
Study publicly available on registry
May 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 27, 2026
March 1, 2026
14.3 years
May 10, 2013
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Sleep Questionnaire
Responses to sleep questionnaire
upon enrollment
Eligibility Criteria
Adult subjects 18 years of age and older who are scheduled for polysomnography (PSG), regardless of final diagnosis AND adult subjects who have already been diagnosed with OSA based on a prior PSG and are already on treatment. OSA diagnosis will be defined as an apnea/hypopnea index (AHI) \>or =5 episodes per hour.
You may qualify if:
- We will recruit subjects who are:
- years of age and older.
- Willing and able to give informed consent
- AND any of the following:
- PSG (polysomnogram)requested by a physician based on clinical grounds
- AHI (Apnea-hypopnea index) ≥ 5 episodes per hour based on a prior PSG.
You may not qualify if:
- Incapable of giving informed consent
- Under the age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suite 2600, Martha Morehouse Medical Pavilion
Columbus, Ohio, 43221, United States
Biospecimen
blood or saliva sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulysses Magalang, MD
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
May 10, 2013
First Posted
May 20, 2013
Study Start
August 1, 2012
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share